Janda Kim 4
4 · Sorrento Therapeutics, Inc. · Filed Sep 14, 2021
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-13$3.50/sh+8,000$28,000→ 11,000 total - Sale
Common Stock
2021-09-13$8.04/sh−8,000$64,285→ 3,000 total - Exercise/Conversion
Non-qualified stock option
2021-09-13−8,000→ 0 totalExercise: $3.50Exp: 2021-09-28→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.84 to $8.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F3]25% of the shares subject to the option vested on September 28, 2012, and 1/48th of the shares subject to the option vested monthly thereafter.